Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edesa Biotech

2.50
+0.03001.21%
Post-market: 2.44-0.0600-2.40%18:39 EDT
Volume:34.46K
Turnover:87.01K
Market Cap:17.34M
PE:-1.33
High:2.60
Open:2.56
Low:2.45
Close:2.47
Loading ...

Analysts Offer Insights on Healthcare Companies: Zai Lab (ZLAB), Perspective Therapeutics (CATX) and Edesa Biotech (EDSA)

TIPRANKS
·
13 Mar

Edesa Biotech Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

Edesa Biotech files to sell 7.81M common shares for holders

TIPRANKS
·
05 Mar

EDSA: Raises $15 Million to Advance EB06…

Zacks Small Cap Research
·
03 Mar

BUZZ-Conagra Brands down after annual profit target cut on supply chain issues

Reuters
·
18 Feb

Edesa Biotech Advances Vitiligo Treatment Amidst Solid Financial Backing

TIPRANKS
·
15 Feb

Edesa Biotech Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Feb

Press Release: Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Dow Jones
·
15 Feb

Edesa Biotech Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
14 Feb

BUZZ-Edesa Biotech to raise $15 million to fund trial; shares rise

Reuters
·
13 Feb

US Stocks Edge Higher; Producer Prices Increase In January

Benzinga
·
13 Feb

Edesa Biotech Inc - Preferred Shares Priced at $10,000, Common Shares at $1.92

THOMSON REUTERS
·
13 Feb

Edesa Biotech Inc - Proceeds to Fund Phase 2 Study of Eb06 for Vitiligo

THOMSON REUTERS
·
13 Feb

Edesa Biotech Announces $15.0 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
13 Feb

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire
·
13 Feb

Edesa Biotech Inc expected to post a loss of 31 cents a share - Earnings Preview

Reuters
·
05 Feb